Extracellular thiols and thiol/disulfide redox in metabolism

Annual Review of Nutrition

Volumn 24, Issue , 2004, Pages 481-509

  Moriarty Craige, Siobhan E ^a   Jones, Dean P ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cysteine; Glutathione; Sulfur amino acids

Indexed keywords

CELL PROTEIN; DISULFIDE; SULFUR; THIOL;

AGING; APOPTOSIS; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURFACE; CENTRAL NERVOUS SYSTEM; HEALTH STATUS; HOMEOSTASIS; HUMAN; IMMUNE FUNCTION TEST; INTESTINE; LIFESTYLE; LUNG; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

AGING; ANIMALS; DISULFIDES; ENERGY METABOLISM; HUMANS; MEMBRANE PROTEINS; OXIDATION-REDUCTION; SULFHYDRYL COMPOUNDS;

EID: 3142685079     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.24.012003.132208     Document Type: Review

References (144)

1. Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, Hollenberg PF. 1996. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 17:821-28
2. Altomare E, Vendemiale G, Albano O. 1988. Hepatic glutathione content in patients with alcoholic and nonalcoholic liver diseases. Life Sci. 43:991-98
3. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, et al. 2002. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99:1491-96
4. Atzori L, Dypbukt JM, Hybbinette SS, Moldeus P, Grafstrom RC. 1994. Modifications of cellular thiols during growth and squamous differentiation of cultured human bronchial epithelial cells. Exp. Cell Res. 211:115-20
5. Badaloo A, Reid M, Forrester T, Heird WC, Jahoor F. 2002. Cysteine supplementation improves the erythrocyte glutathione synthesis rate in children with severe edematous malnutrition. Am. J. Clin. Nutr. 76:646-52
6. Bains JS, Shaw CA. 1997. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 25: 335-58
7. Breitkreutz R, Pittack N, Nebe CT, Schuster D, Brust J, et al. 2000. Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials. J. Mol. Med. 78:55-62
8. Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, et al. 1989. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2:1294-98
9. Burk RF, Hill KE. 1995. Reduced glutathione release into rat plasma by extrahepatic tissues. Am. J. Physiol. Gastrointest. Liver Physiol. 269:G396-99
10. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. 2000. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19:205-21
11. Cai J, Sun WM, Lu SC. 1995. Hormonal and cell density regulation of hepatic gamma-glutamylcysteine synthetase gene expression. Mol. Pharmacol. 48:212-18
12. Cantor EJ, Mancini EV, Seth R, Yao XH, Netticadan T. 2003. Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy. Curr. Hypertens. Rep. 5:215-20
13. Cavallini L, Alexandre A. 2000. Oral N-acetyl-cysteome increases the production of anti-HIV chemokines in peripheral blood mononuclear cells. Life Sci. 67: 147-54
14. Chawla RK, Lewis FW, Kutner MH, Bate DM, Roy RG, Rudman D. 1984. Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology 87:770-76
15. Costagliola C, Iuliano G, Menzione M, Nesti A, Simonelli F, Rinaldi E. 1988. Systemic human diseases as oxidative risk factors in cataractogenesis. I. Diabetes. Ophthalmic Res. 20:308-16
16. Cotgreave IA, Gerdes RG. 1998. Recent trends in glutathione biochemistry - glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun. 242:1-9
17. Cudkowicz ME, Sexton PM, Ellis T, Hayden DL, Gwilt PR, et al. 1999. The pharmacokinetics and pharmaco-dynamics of procysteine in amyotrophic lateral sclerosis. Neurology 52:1492-94
18. Dahm LJ, Jones DP. 2000. Rat jejunum controls luminal thiol-disulfide redox. J. Nutr. 130:2739-45
19. Dickinson DA, Forman HJ. 2002. Glutathione in defense and signaling: lessons from a small thiol. Ann. NY Acad. Sci. 973:488-504
20. Droge W, Eck HP, Gmunder H, Mihm S. 1991. Requirement for prooxidant and antioxidant states in T cell mediated immune responses - relevance for the pathogenetic mechanisms of AIDS? Klin. Wochenschr. 69:1118-22
21. Eberle D, Clarke R, Kaplowitz N. 1981. Rapid oxidation in vitro of endogenous and exogenous glutathione in bile of rats. J. Biol. Chem. 256:2115-17
22. Eck HP, Gmunder H, Hartmann M, Petzoldt D, Daniel V, Droge W. 1989. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe Seyler 370:101-8
23. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. 2002. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging 23:719-35
24. Fahey JW, Talalay P. 1999. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem. Toxicol. 37:973-79
25. Fechner A, Bohme C, Gromer S, Funk M, Schirmer R, Becker K. 2001. Antioxidant status and nitric oxide in the malnutrition syndrome kwashiorkor. Pediatr. Res. 49:237-43
26. Flagg EW, Coates RJ, Eley JW, Jones DP, Gunter EW, et al. 1994. Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level. Nutr. Cancer 21:33-46
27. Flagg EW, Coates RJ, Jones DP, Byers TE, Greenberg RS, et al. 1994. Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am. J. Epidemiol. 139:453-65
28. Foreman MG, Hoor TT, Brown LA, Moss M. 2002. Effects of chronic hepatic dysfunction on pulmonary glutathione homeostasis. Alcohol Clin. Exp. Res. 26:1840-45
29. Forrester TE, Badaloo V, Bennett FI, Jackson AA. 1990. Excessive excretion of 5-oxoproline and decreased levels of blood glutathione in type II diabetes mellitus. Em. J. Clin. Nutr. 44:847-50
30. Gey KF. 1995. Cardiovascular disease and vitamins. Concurrent correction of "suboptimal" plasma antioxidant levels may, as important part of "optimal" nutrition, help to prevent early stages of cardiovascular disease and cancer, respectively. Bibl. Nutr. Dieta 52:75-91
31. Gmunder H, Eck HP, Benninghoff B, Roth S, Droge W 1990. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol. 129:32-46
32. Golden MH, Ramdath D. 1987. Free radicals in the pathogenesis of kwashiorkor. Proc. Nutr. Soc. 46:53-68
33. Guidot D, Moss M, Holguin F, Lois M, Brown L. 1999. Ethanol ingestion impairs alveolar epithelial glutathione homeostasis and function, and predisposes to endotoxin-mediated acute lung injury. Chest 116:828
34. Gulati P, Klohn PC, Krug H, Gottlicher M, Markova B, et al. 2001. Redox regulation in mammalian signal transduction. IUBMB Life 52:25-28
35. Hack V, Breitkreutz R, Kinscherf R, Rohrer H, Bartsch P, et al. 1998. The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 92:59-67
36. Halliwell B. 1996. Antioxidants in human health and disease. Annu. Rev. Nutr. 16:33-50
37. Hildebrandt W, Kinscherf R, Hauer K, Holm E, Droge W. 2002. Plasma cystine concentration and redox state in aging and physical exercise. Mech. Ageing Dev. 123:1269-81
38. Hudson VM. 2001. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic. Biol. Med. 30:1440-61
39. Hunter EA, Grimble RF. 1997. Dietary sulphur amino acid adequacy influences glutathione synthesis and glutathione-dependent enzymes during the inflammatory response to endotoxin and tumour necrosis factor-alpha in rats. Clin. Sci. 92:297-305
40. Husain D, Ambati B, Adamis AP, Miller JW. 2002. Mechanisms of age-related macular degeneration. Ophthalmol. Clin. North Am. 15:87-91
41. Hutter D, Greene JJ. 2000. Influence of the cellular redox state on NF-κB-regulated gene expression. J. Cell Physiol. 183:45-52
42. Hutter DE, Till BG, Greene JJ. 1997. Redox state changes in density-dependent regulation of proliferation. Exp. Cell Res. 232:435-38
43. Hwang C, Sinskey AJ. 1991. The role of oxidation-reduction potential in monitoring growth of cultured mammalian cells. In Production of Biologicals from Animal Cells in Culture, ed. RE Spier, JB Griffiths, B Meignier, pp. 548-67. Oxford: Halley Court
44. Hwang C, Sinskey AJ, Lodish HF. 1992. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257:1496-502
45. 2+ influx. Arterioscler. Thromb. Vasc. Biol. 20:2359-65
46. Inayama T, Kumagai Y, Sakane M, Saito M, Matsuda M. 1996. Plasma protein-bound sulfhydryl group oxidation in humans following a full marathon race. Life Sci. 59:573-78
47. Ishii T, Hishinuma I, Bannai S, Sugita Y. 1981. Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol. J. Cell Physiol. 107:283-93
48. Ishii T, Sugita Y, Bannai S. 1987. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell Physiol. 133:330-36
49. Iwata S, Hori T, Sato N, Hirota K, Sasada T, et al. 1997. Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. J. Immunol. 158:3108-17
50. Iwata S, Hori T, Sato N, Ueda-Taniguchi Y, Yamabe T, et al. 1994. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression. J. Immunol. 152:5633-42
51. Jackson AA. 1986. Blood glutathione in severe malnutrition in childhood. Trans. R. Soc. Trop. Med. Hyg. 80:911-13
52. Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, et al. 1995. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr. Pulmonol. 20:160-66
53. Jiang S, Cai J, Wallace DC, Jones DP. 1999. Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved. J. Biol. Chem. 274:29905-11
54. Jiang S, Moriarty SE, Grossniklaus H, Nelson KC, Jones DP, Sternberg P Jr. 2002. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 43:2546-53
55. Jiang S, Moriarty SE, Miller NR, Jones DP, Sternberg P. 2001. Regulations of human retinal pigment epithelial (hRPE) cell growth and cellular glutathione/glutathione disulfide (GSH/GSSG) redox status by changing extracellular cysteine/cystine (Cys/CySS). Invest. Ophthalmol. Vis. Sci. 42:B75
56. Jikimoto T, Nishikubo Y, Koshiba M, Kanagawa S, Morinobu S, et al. 2002. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol. Immunol. 38:765-72
57. Jonas CR, Gu LH, Nkabyo Y, Mannery YO, Avissar NE, et al. 2003. Glutamine and KGF each regulate extracellular thiol/disulfide redox and enhance proliferation in Caco-2 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R1421-29
58. Jonas CR, Ziegler TR, Gu LH, Jones DP. 2002. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic. Biol. Med. 33:1499-506
59. Jones DP. 2002. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 348:93-112
60. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, Sternberg P. 2000. Redox state of glutathione inhuman plasma. Free Radic. Biol. Med. 28:625-35
61. Jones DP, Coates RJ, Flagg EW, Eley JW, Block G, et al. 1992. Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire. Nutr. Cancer 17:57-75
62. Jones DP, Maellaro E, Jiang S, Slater AF, Orrenius S. 1995. Effects of N-acetyl-L-cysteine on T-cell apoptosis are not mediated by increased cellular glutathione. Immunol. Lett. 45:205-9
63. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr. 2002. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic. Biol. Med. 33:1290-300
64. Jovanovic SV, Simic MG. 2000. Antioxidants in nutrition. Ann. NY Acad. Sci. 899:326-34
65. Kensler TW, Curphey TJ, Maxiutenko Y, Roebuck BD. 2000. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol. Drug Interact. 17:3-22
66. Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP. 1999. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic. Biol. Med. 27:1208-18
67. Kobayashi F, Sagawa N, Nanbu Y, Kitaoka Y, Mori T, et al. 1995. Biochemical and topological analysis of adult T-cell leukaemia-derived factor, homologous to thioredoxin, in the pregnant human uterus. Hum. Reprod. 10:1603-8
68. Kovacic P, Jacintho JD. 2001. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem. 8:773-96
69. Kretzschmar M, Muller D, Hubscher J, Marin E, Klinger W. 1991. Influence of aging, training and acute physical exercise on plasma glutathione and lipid peroxides in man. Int. J. Sports Med. 12:218-22
70. Kretzschmar M, Pfeifer U, Machnik G, Klinger W. 1992. Glutathione homeostasis and turnover in the totally hepatectomized rat: evidence for a high glutathione export capacity of extrahepatic tissues. Exp. Toxicol. Pathol. 44:273-81
71. Lew H, Pyke S, Quintanilha A. 1985. Changes in the glutathione status of plasma, liver and muscle following exhaustive exercise in rats. FEBS Lett. 185: 262-66
72. Li WQ, Dehnade F, Zafarullah M. 2000. Thiol antioxidant, N-acetylcysteine, activates extracellular signal-regulated kinase signaling pathway in articular chondrocytes. Biochem. Biophys. Res. Commun. 275:789-94
73. Lioy J, Ho WZ, Cutilli JR, Polin RA, Douglas SD. 1993. Thiol suppression of human immunodeficiency virus type 1 replication in primary cord blood monocyte-derived macrophages in vitro. J. Clin. Invest. 91:495-98
74. Lipinski B. 2001. Pathophysiology of oxidative stress in diabetes mellitus. J. Diabetes Complicat. 15:203-10
75. Loguercio C, Del Vecchio Blanco C, Coltorti M, Nardi G. 1992. Alteration of erythrocyte glutathione, cysteine and glutathione synthetase in alcoholic and non-alcoholic cirrhosis. Scand. J. Clin. Lab. Invest. 52:207-13
76. Loguercio C, Nardi G, Prota G, Del Vecchio Blanco C, Coltorti M. 1990. Decrease of total glutathione and cysteine SH in non-alcoholic cirrhosis. Ital. J. Gastroenterol. 22:13-15
77. Loguercio C, Piscopo P, Guerriero C, De Girolamo V, Disalvo D, Del Vecchio Blanco C. 1996. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis. Scand. J. Clin. Lab. Invest. 56:441-47
78. Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, Sartorelli AC. 1997. Disruption of the mutine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:5238-42
79. Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, Lu XM, Zurakowski D, et al. 2001. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit. Care Med. 29:870-77
80. Lyons J, Rauh-Pfeiffer A, Yu YM, Lu XM, Zurakowski D, et al. 2000. Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet. Proc. Natl. Acad. Sci. USA 97:5071-76
81. Malmezat T, Breuille D, Capitan P, Mirand PP, Obled C. 2000. Glutathione turnover is increased during the acute phase of sepsis in rats. J. Nutr. 130:1239-46
82. Malorni W, Rivabene R, Santini MT, Donelli G. 1993. N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett. 327:75-78
83. Marin E, Kretzschmar M, Arokoski J, Hanninen O, Klinger W. 1993. Enzymes of glutathione synthesis in dog skeletal muscles and their response to training. Acta Physiol. Scand. 147:369-73
84. Martensson J, Jain A, Meister A. 1990. Glutathione is required for intestinal function. Proc. Natl. Acad. Sci. USA 87:1715-19
85. Maxwell S, Greig L. 2001. Antioxidants - a protective role in cardiovascular disease? Expert Opin. Pharmacother. 2:1737-50
86. Mehta RG, Liu J, Constantinou A, Thomas CF, Hawthorne M, et al. 1995. Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis 16:399-404
87. Meister A. 1991. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacol. Ther. 51:155-94
88. Mezencev R, Mojzis J, Pilatova M, Kutschy P. 2003. Antiproliferative and cancer chemopreventive activity of phytoalexins: focus on indole phytoalexins from crucifers. Neoplasma 50:239-45
89. Miller LT, Watson WH, Kirlin WG, Ziegler TR, Jones DP. 2002. Oxidation of the glutathione/glutathione disulfideredox state is induced by cysteine deficiency in human colon carcinoma HT29 cells. J. Nutr. 132:2303-6
90. Moran LK, Gutteridge JM, Quinlan GJ. 2001. Thiols in cellular redox signalling and control. Curr. Med. Chem. 8:763-72
91. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, et al. 2004. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic. Biol. Med. In press
92. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. 2000. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am. J. Respir. Crit. Care Med. 161:414-19
93. Murakami K, Kondo T, Ohtsuka Y, Fujiwara Y, Shimada M, Kawakami Y. 1989. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38:753-58
94. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, et al. 1996. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 8:603-11
95. Nakamura H, De Rosa SC, Yodoi J, Holmgren A, Ghezzi P, Herzenberg LA. 2001. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc. Natl. Acad. Sci. USA 98:2688-93
96. Nakamura H, Nakamura K, Yodoi J. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351-69
97. Nakashima I, Kato M, Akhand AA, Suzuki H, Takeda K, et al. 2002. Redox-linked signal transduction pathways for protein tyrosine kinase activation. Antioxid. Redox Signal. 4:517-31
98. Nkabyo YS, Ziegler TR, Gu LH, Watson WH, Jones DP. 2002. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283:01352-59
99. Noda T, Iwakiri R, Fujimoto K, Aw TY. 2001. Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells. FASEB J. 15:2131-39
100. Noda T, Iwakiri R, Fujimoto K, Rhoads CA, Aw TY. 2002. Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells. Cell Prolif. 35:117-29
101. Orlowski M, Karkowsky A. 1976. Glutathione metabolism and some possible functions of glutathione in the nervous system. Int. Rev. Neurobiol. 19:75-121
102. Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, et al. 2000. Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J. Gastrointest. Surg. 4:416-23
103. Papaconstantinou HT, Hwang KO, Rajaraman S, Hellmich MR, Townsend CM Jr, Ko TC. 1998. Glutamine deprivation induces apoptosis in intestinal epithelial cells. Surgery 124:152-59; discussion 59-60
104. Park EJ, Pezzuto JM. 2002. Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 21:231-55
105. Puka-Sundvall M, Fjiksson P, Nilsson M, Sandberg M, Lehmann A. 1995. Neurotoxicity of cysteine: interaction with glutamate. Brain Res. 705:65-70
106. Pyke S, Lew H, Quintanilha A. 1986. Severe depletion in liver glutathione during physical exercise. Biochem. Biophys. Res. Commun. 139:926-31
107. Rahman I, MacNee W. 1999. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277:L1067-88
108. Rao AV, Balachandran B. 2002. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5:291-309
109. Rappa G, Lorico A, Flavell RA, Sartorelli AC. 1997. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57:5232-37
110. Reddy S, Finkelstein EI, Wong PS, Phung A, Cross CE, van der Vliet A. 2002. Identification of glutathione modifications by cigarette smoke. Free Radic. Biol. Med. 33:1490-98
111. Regan RF, Guo Y. 1999. Extracellular reduced glutathione increases neuronal vulnerability to combined chemical hypoxia and glucose deprivation. Brain Res. 817:145-50
112. Regan RF, Guo YP. 1999. Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione. Neurosdence 91:463-70
113. Rehncrona S, Folbergrova J, Smith DS, Siesjo BK. 1980. Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J. Neurochem. 34:477-86
114. Reid M, Badaloo A, Forrester T, Morlese JF, Frazer M, et al. 2000. In vivo rates of erytnrocyte glutathione synthesis in children with severe protein-energy malnutrition. Am. J. Physiol. Endocrinol. Metab. 278:E405-12
115. Roum JH, Aledia AS, Carungcong LA, Kim KJ, Borok Z. 2001. Extracellular glutathione inhibits oxygen-induced permeability changes in alveolar epithelial monolayers. J. Appl. Physiol. 91:748-54
116. Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG. 1993. Systemic deficiency of glutathione in cystic fibrosis. J. Appl. Physiol. 75:2419-24
117. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Stemberg P Jr, et al. 1998. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 24:699-704
118. Sandstrom PA, Mannie MD, Buttke TM. 1994. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J. Leukoc. Biol. 55:221-26
119. Sato H, Tamba M, Ishii T, Bannai S. 1999. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274:11455-58
120. Schafer FQ, Buettner GR. 2001. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30:1191-212
121. Scharrer E, Senn E, Wolffram S. 1992. Stimulation of mucosal uptake of selenium from selenite by some thiols at various sites of rat intestine. Biol. Trace Elem. Res. 33:109-20
122. Senn E, Scharrer E, Wolffram S. 1992. Effects of glutathione and of cysteine on intestinal absorption of selenium from selenite. Biol. Trace Elem. Res. 33:103-8
123. Shor-Posner G, Lecusay R, Morales G, Campa A, Miguez-Burbano MJ. 2002. Neuroprotection in HIV-positive drug users: implications for antioxidant therapy. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2):S84-88
124. Sido B, Braunstein J, Breitkreutz R, Herfarth C, Meuer SC. 2000. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J. Exp. Med. 192:907-12
125. Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. 1998. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 42:485-92
126. Sirsjo A, Arstrand K, Kagedal B, Nylander G, Gidlof A. 1996. In situ microdialysis for monitoring of extracellular glutathione levels in normal, ischemic and post-ischemic skeletal muscle. Free Radic. Res. 25:385-91
127. Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH. 1996. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol. Appl. Pharmacol. 140:1-12
128. Snary D, Allen A, Pain RH. 1970. Structural studies on gastric mucoproteins: lowering of molecular weight after reduction with 2-mercaptoethanol. Biochem. Biophys. Res. Commun. 40:844-51
129. Soderberg A, Sahaf B, Rosen A. 2000. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res. 60:2281-89
130. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, et al. 2003. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J. Hepatol. 38:32-38
131. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, et al. 2000. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J. Hepatol. 33:616-22
132. Tohgi H, Abe T, Saheki M, Hamato F, Sasaki K, Takahashi S. 1995. Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of Parkinsonian patients: comparison between before and after L-dopa treatment. Neurosci. Lett. 184:21-24
133. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. 1999. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci. Lett. 260:204-6
134. Traber MG, van der Vliet A, Reznick AZ, Cross CE. 2000. Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Clin. Chest Med. 21:173-87
135. Tribble DL, Jones DP, Ardehali A, Feeley RM, Rudman D. 1989. Hypercysteinemia and delayed sulfur excretion in cirrhotics after oral cysteine loads. Am. J. Clin. Nutr. 50:1401-6
136. Tsunada S, Iwakiri R, Noda T, Fujimoto K, Fuseler J, et al. 2003. Chronic exposure to subtoxic levels of peroxidized lipids suppresses mucosal cell turnover in rat small intestine and reversal by glutathione. Dig. Dis. Sci. 48:210-22
137. Van Campen D. 1973. Enhancement of iron absorption from ligated segments of rat intestine by histidine, cysteine, and lysine: effects of removing ionizing groups and of stereoisomerism. J. Nutr. 103:139-42
138. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, et al. 1990. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. USA 87:8282-86
139. Watanabe H, Bannai S. 1987. Induction of cystine transport activity in mouse peritoneal macrophages. J. Exp. Med. 165: 628-40
140. Watson WH, Cai J, Jones DP. 2000. Diet and apoptosis. Annu. Rev. Nutr. 20:485-505
141. Watson WH, Jones DP. 2003. Oxidation of nuclear thioredoxin during oxidative stress. FEBS Lett. 543:144-47
142. Yamada Y, Nakamura H, Adachi T, Sannohe S, Oyamada H, et al. 2003. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol. Lett. 86:199-205
143. Yang CS, Chou ST, Lin NN, Liu L, Tsai PJ, et al. 1994. Determination of extracellular glutathione in rat brain by microdialysis and high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Appl. 661:231-35
144. Zangerle L, Cuenod M, Winterhalter KH, Do KQ. 1992. Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J. Neurochem. 59:181-89